Arkolith/Insider Trading/PHAT/Form 4

Parikh Asit

DirectorPhathom Pharmaceuticals, Inc. (PHAT) · full profile →Form 4 · filed Mar 21, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 10, 2024Option exercise(M)8K$11.72$88K93K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 10, 2024Option exercise(M)8K—$08K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-043291) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML